The US FDA Approves Zoetis’ Simparica Trio to Prevent Flea Tapeworm Infections in Dogs
Shots:
- The US FDA has approved label expansion of Simparica Trio to protect dogs against Dipylidium caninum (flea tapeworm) infections by killing Ctenocephalides felis vector fleas
- Simparica Trio (sarolaner, moxidectin, & pyrantel) is a parasiticide that protects dogs against heartworm disease, 6 tick species (incl. Lyme-transmitting deer ticks), fleas, roundworms, hookworms, & flea tapeworms
- Simparica Trio is a highly palatable, monthly chewable tablet that starts killing fleas within 4 hrs. & can be administered with or without food
Ref: Zoetis | Image: Zoetis
Related News:- Zoetis Reports Clinical Data of Librela for Canine Osteoarthritis Pain
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Ridhi is an avid secondary researcher who follows trends in the biopharmaceutical and healthcare sectors to curate engaging content for the global audience. She works as a news editor at PharmaShots and loves to read books and explore new destinations.
